ABUS · ISSUER CIK 1447028
Arbutus Biopharma Corp
Between Aug 1, 2026 and Oct 29, 2026, 5 Arbutus Biopharma Corp insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202616:12 | Oct 1, 2026 | ABUS | Director | D · To issuerLate 6d | $5.00 | −17,948 | 14,328 | -56% | $90K | ||
| Oct 7, 202616:11 | Oct 1, 2026 | ABUS | Chief Financial Officer | D · To issuerLate 6d | $5.00 | −48,081 | 111,882 | -30% | $240K | ||
| Oct 7, 202616:09 | Oct 1, 2026 | ABUS | Director | D · To issuerLate 6d | $5.00 | −17,142 | 13,683 | -56% | $86K | ||
| Oct 7, 202616:09 | Oct 1, 2026 | ABUS | President and CEO, Director | D · To issuerLate 6d | $5.00 | −24,655 | 47,682 | -34% | $123K | ||
| Oct 5, 202621:00 | Oct 1, 2026 | ABUS | Director, 10% Owner | D · To issuer | $5.00 | −8,967,383 | 29,880,079 | -23% | $44.8M | ||
| Sep 23, 202620:32 | Sep 18, 2026 | ABUS | President and CEO, Director | M · ExerciseLate 5d | $3.30 | +126,864 | 154,864 | +453% | $418K | ||
| Sep 23, 202620:32 | Sep 18, 2026 | ABUS | President and CEO, Director | F · TaxLate 5d | $5.07 | −82,527 | 72,337 | -53% | $418K | ||
| Sep 23, 202620:31 | Sep 18, 2026 | ABUS | Chief Financial Officer | M · ExerciseLate 5d | $3.57 | +293,100 | 366,600 | +399% | $1.0M | ||
| Sep 23, 202620:31 | Sep 18, 2026 | ABUS | Chief Financial Officer | F · TaxLate 5d | $5.07 | −206,637 | 159,963 | -56% | $1.0M | ||
| Sep 23, 202620:31 | Sep 18, 2026 | ABUS | Director | M · ExerciseLate 5d | $3.88 | +131,333 | 131,333 | New | $510K | ||
| Sep 23, 202620:31 | Sep 18, 2026 | ABUS | Director | F · TaxLate 5d | $5.07 | −100,508 | 30,825 | -77% | $510K | ||
| Sep 23, 202620:31 | Sep 18, 2026 | ABUS | Director | M · ExerciseLate 5d | $3.82 | +131,333 | 131,333 | New | $502K | ||
| Sep 23, 202620:31 | Sep 18, 2026 | ABUS | Director | F · TaxLate 5d | $5.07 | −99,057 | 32,276 | -75% | $502K |